Right ventricular dysfunction by computed tomography associates with outcomes in severe aortic stenosis patients undergoing transcatheter aortic valve replacement

Published:November 13, 2021DOI:



      Although cardiac computed tomography angiography (CCTA) assessment of right ventricular dysfunction (RVD) is feasible, the incremental prognostic value remains uncertain in patients undergoing transcatheter aortic valve replacement (TAVR) evaluation. This study sought to determine the incremental clinical utility of RVD identification by CCTA while accounting for clinical and echocardiographic parameters.


      Patients who underwent multiphasic ECG-gated functional CCTA using dual-source system for routine TAVR planning were evaluated. Biphasic contrast protocol injection allowed for biventricular contrast enhancement. CCTA-based RVD was defined as right ventricular ejection fraction (RVEF) ​< ​50%. The association of CCTA-RVD with all-cause mortality and the composite outcome of death or heart failure hospitalization after TAVR was evaluated and examined for its incremental utility beyond clinical risk assessment and echocardiographic parameters.


      A total of 502 patients were included (median [IQR] age, 82 [77 to 87] years; 56% men) with a median follow-up of 22 [16 to 32] months. Importantly, 126 (25%) patients were identified as having RVD by CCTA that was not identified by echocardiography. CCTA-defined RVD predicted death and the composite outcome in both univariate analyses (HR for mortality, 2.15; 95% CI, 1.44–3.22; p ​< ​0.001; HR for composite outcome, 2.11; 95% CI, 1.48–3.01; p ​< ​0.001) and in multivariate models that included clinical risk factors and echocardiographic findings (HR for mortality, 1.74; 95% CI, 1.11–2.74; p ​= ​0.02; HR for composite outcome, 1.63; 95% CI, 1.09–2.44; p ​= ​0.02).


      Functional CCTA assessment pre-TAVR correctly identified 25% of patients with RVD that was not evident on 2D echocardiography. The presence of RVD on CCTA independently associates with clinical outcomes post-TAVR.



      AS (aortic stenosis), CCTA (cardiac computed tomography angiography), FAC (fractional area change), RVEF (right ventricular ejection fraction), RVD (right ventricular dysfunction), TAPSE (tricuspid annular plane systolic excursion), TAVR (transcatheter aortic valve replacement), TTE (transthoracic echocardiography)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      Full access to the journal is a member benefit for SCCT Members, Login via the SCCT website to access all journal content.


      Subscribe to Journal of Cardiovascular Computed Tomography
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cavalcante J.L.
        • Simon M.A.
        • Chan S.Y.
        Comprehensive right-sided assessment for transcatheter aortic valve replacement risk stratification: time for a change.
        J Am Soc Echocardiogr. 2017; 30: 47-51
        • Genereux P.
        • Pibarot P.
        • Redfors B.
        • et al.
        Staging classification of aortic stenosis based on the extent of cardiac damage.
        Eur Heart J. 2017; 38: 3351-3358
        • Fukui M.
        • Gupta A.
        • Abdelkarim I.
        • et al.
        Association of structural and functional cardiac changes with transcatheter aortic valve replacement outcomes in patients with aortic stenosis.
        JAMA Cardiol. 2019; 4: 215-222
        • Asami M.
        • Stortecky S.
        • Praz F.
        • et al.
        Prognostic value of right ventricular dysfunction on clinical outcomes after transcatheter aortic valve replacement.
        JACC Cardiovasc Imag. 2019; 12: 577-587
        • Lang R.M.
        • Badano L.P.
        • Mor-Avi V.
        • et al.
        Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
        J Am Soc Echocardiogr. 2015; 28: 1-39 e14
        • Grevious S.N.
        • Fernandes M.F.
        • Annor A.K.
        • et al.
        Prognostic assessment of right ventricular systolic dysfunction on post-transcatheter aortic valve replacement short-term outcomes: systematic Review and meta-analysis.
        J Am Heart Assoc. 2020; 9e014463
        • Baumgartner H.
        • Falk V.
        • Bax J.J.
        • et al.
        2017 ESC/EACTS Guidelines for the management of valvular heart disease.
        Eur Heart J. 2017; 38: 2739-2791
        • Writing Committee M.
        • Otto C.M.
        • Nishimura R.A.
        • et al.
        2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American heart association joint Committee on clinical practice guidelines.
        J Am Coll Cardiol. 2021; 77: 450-500
        • Rist C.
        • Johnson T.R.
        • Muller-Starck J.
        • et al.
        Noninvasive coronary angiography using dual-source computed tomography in patients with atrial fibrillation.
        Invest Radiol. 2009; 44: 159-167
        • Wolak A.
        • Gutstein A.
        • Cheng V.Y.
        • et al.
        Dual-source coronary computed tomography angiography in patients with atrial fibrillation: initial experience.
        J Cardiovasc Comput Tomogr. 2008; 2: 172-180
        • Suh Y.J.
        • Im D.J.
        • Hong Y.J.
        • et al.
        Absolute-delay multiphase reconstruction reduces prosthetic valve-related and atrial fibrillation-related artifacts at cardiac CT.
        AJR Am J Roentgenol. 2017; 208: W160-W167
        • Baumgartner H.
        • Hung J.
        • Bermejo J.
        • et al.
        Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European association of cardiovascular imaging and the American society of echocardiography.
        J Am Soc Echocardiogr. 2017; 30: 372-392
        • Harjola V.P.
        • Mebazaa A.
        • Celutkiene J.
        • et al.
        Contemporary management of acute right ventricular failure: a statement from the heart failure association and the working group on pulmonary circulation and right ventricular function of the European society of cardiology.
        Eur J Heart Fail. 2016; 18: 226-241
        • Alushi B.
        • Beckhoff F.
        • Leistner D.
        • et al.
        Pulmonary hypertension in patients with severe aortic stenosis: prognostic impact after transcatheter aortic valve replacement: pulmonary hypertension in patients undergoing TAVR.
        JACC Cardiovasc Imag. 2019; 12: 591-601
        • Zoghbi W.A.
        • Adams D.
        • Bonow R.O.
        • et al.
        Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance.
        J Am Soc Echocardiogr. 2017; 30: 303-371
        • Kappetein A.P.
        • Head S.J.
        • Genereux P.
        • et al.
        Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
        J Am Coll Cardiol. 2012; 60: 1438-1454
        • Takx R.A.
        • Moscariello A.
        • Schoepf U.J.
        • et al.
        Quantification of left and right ventricular function and myocardial mass: comparison of low-radiation dose 2nd generation dual-source CT and cardiac MRI.
        Eur J Radiol. 2012; 81: e598-604
        • Kawel-Boehm N.
        • Hetzel S.J.
        • Ambale-Venkatesh B.
        • et al.
        Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update.
        J Cardiovasc Magn Reson. 2020; 22: 87
        • Vollema E.M.
        • Amanullah M.R.
        • Ng A.C.T.
        • et al.
        Staging cardiac damage in patients with symptomatic aortic valve stenosis.
        J Am Coll Cardiol. 2019; 74: 538-549
        • Okuno T.
        • Heg D.
        • Lanz J.
        • et al.
        Staging cardiac damage associated with aortic stenosis in patients undergoing transcatheter aortic valve implantation.
        Int J Cardiol Heart Vasculat. 2021; 33100768
        • Schwartz L.A.
        • Rozenbaum Z.
        • Ghantous E.
        • et al.
        Impact of right ventricular dysfunction and tricuspid regurgitation on outcomes in patients undergoing transcatheter aortic valve replacement.
        J Am Soc Echocardiogr. 2017; 30: 36-46
        • Lindman B.R.
        • Maniar H.S.
        • Jaber W.A.
        • et al.
        Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort.
        Circ Cardiovasc Interv. 2015; 8
        • Addetia K.
        • Muraru D.
        • Badano L.P.
        • Lang R.M.
        New directions in right ventricular assessment using 3-dimensional echocardiography.
        JAMA Cardiol. 2019; 4: 936-944
        • Muraru D.
        • Badano L.P.
        • Nagata Y.
        • et al.
        Development and prognostic validation of partition values to grade right ventricular dysfunction severity using 3D echocardiography.
        Eur Heart J Cardiovasc Imag. 2020; 21: 10-21
        • Burghard P.
        • Plank F.
        • Beyer C.
        • et al.
        Evaluation of right ventricular function by coronary computed tomography angiography using a novel automated 3D right ventricle volume segmentation approach: a validation study.
        Eur Radiol. 2018; 28: 5129-5136
        • Kwak S.
        • Everett R.J.
        • Treibel T.A.
        • et al.
        Markers of myocardial damage predict mortality in patients with aortic stenosis.
        J Am Coll Cardiol. 2021; 78: 545-558